Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 382.00
Bid: 374.00
Ask: 384.00
Change: 12.00 (3.24%)
Spread: 10.00 (2.674%)
Open: 382.00
High: 382.00
Low: 382.00
Prev. Close: 370.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Jul 2009 07:00

RNS Number : 2015V
Microgen PLC
07 July 2009
 



microgen

www.microgen.com

 7 July 2009

M icrogen plc

Trading Update

Microgen plc ('Microgen' or 'the Group'provides an update on trading ahead of the Group's Interim Results, for the six months ended 30 June 2009, which are anticipated to be released in late July. 

During the first half of 2009, Microgen Aptitude Solutions Division ("MASD") has seen considerable success. In addition to the multi-million pound contract reported in the April Interim Management Statementthe division is also now engaged on three significant new customer projects :

Major UK Bank : MASD has recently signed a contract for Microgen Accounting Hub and Microgen Aptitude. This project is anticipated to produce revenue in excess of £1 million in the coming year.

US Manufacturer : In parallel with final contract negotiations, MASD is commencing the initial design phase of a project for Microgen Aptitude which is also anticipated to produce revenue in excess of £1 million in the coming year.

Major US Financial Institution : MASD is currently undertaking a significant customer-funded proof-of-concept which may or may not lead to a major contract for Microgen Aptitude and/or Microgen Accounting Hub.

As a result of these projects and additional prospects, the Board anticipates MASD delivering a strong second half of the year. The operating loss for MASD in the first-half has significantly reduced compared to the prior year. Microgen expenses all development costs as incurred and has no R&D capitalisation on its balance sheet. This results in a high correlation between operating income and cash flow for the Group as a whole and, as the revenue increases within MASD, profitability of this division should scale accordingly.

As anticipated, the Group's Billing Services Division and Financial Systems Division have reflected the economic climate but are trading in line with the Board's expectations. These divisions have high recurring revenue and hence remain profitable, high margin businesses with strong cash flow.

Cash at 30 June 2009 was £15.2 million, compared to £14.7 million at 31 December 2008, after repayment of £1.3 million of the loan associated with the freehold property and payment of the final dividend of £1.2 million.

Overall, despite the continuing difficult market environment, the first half of 2009 is anticipated to be in line with the Board's expectations, but, as a result of the strong MASD performance, and subject to contracts being finalised for the two projects noted aboveearnings for the year are anticipated to be ahead of current market expectations.

Contacts

Martyn Ratcliffe, Chairman

01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

Giles Sanderson, Financial Dynamics

Haya Chelhot, Financial Dynamics

020-7831-3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBSGDRXXGGGCL
Date   Source Headline
4th Apr 20227:00 amRNSGrant of awards under 2020 Deferred Bonus Plan
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSAudited Preliminary Results
1st Mar 20221:00 pmRNSTotal Voting Rights
1st Feb 202211:05 amRNSTotal Voting Rights
20th Jan 20227:00 amRNSTrading Update and Notice of Results
1st Dec 20217:00 amRNSTotal Voting Rights
8th Nov 20215:05 pmRNSGrant of awards under Performance Share Plan
1st Nov 20214:50 pmRNSTotal Voting Rights
25th Oct 20217:00 amRNSBlock Listing Application
11th Oct 20217:00 amRNSAcquisition of MPP Global Solutions Limited
1st Oct 20217:00 amRNSNon-Executive Directorate and Committee Changes
28th Sep 202111:24 amRNSBlock listing Interim Review
17th Sep 20217:00 amRNSChange of Auditor
28th Jul 20217:00 amRNSInterim Results
16th Jul 20217:00 amRNSNotice of Results
6th Jul 202110:39 amRNSHolding(s) in Company
1st Jul 20217:00 amRNSTotal Voting Rights
15th Jun 20219:57 amRNSDirector Declaration
27th May 20218:20 amRNSDirector Declaration
6th May 20213:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20213:27 pmRNSHolding(s) in Company
4th May 20218:55 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSAppointment of Joint Broker
27th Apr 202111:28 amRNSResult of AGM
27th Apr 20217:00 amRNSAGM Statement
9th Apr 202111:14 amRNSHolding(s) in Company
29th Mar 20212:06 pmRNSBlock listing Interim Review
23rd Mar 202111:13 amRNSDirector/PDMR Shareholding
11th Mar 20214:44 pmRNSBlock Listing Application
2nd Mar 20217:00 amRNSNotice of Results
1st Mar 202112:36 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSTrading Update
6th Jan 20214:23 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20209:13 amRNSHolding(s) in Company
1st Dec 202010:09 amRNSTotal Voting Rights
23rd Nov 20205:37 pmRNSHolding(s) in Company
28th Oct 20201:58 pmRNSDirector/PDMR Shareholding
29th Sep 20204:41 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 202010:48 amRNSBlock listing Interim Review
9th Sep 20204:24 pmRNSGrant of awards under Performance Share Plan
2nd Sep 20201:38 pmRNSDirector Declaration
11th Aug 202012:19 pmRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSInterim Results
6th Jul 20207:23 amRNSHolding(s) in Company
6th Jul 20207:21 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.